HINDWARE HME INOVATON Latest Share Price (HINDWAREAP)
TODAY IN ONE LINE
HINDWAREAP fell 1.0% on light volume, in line with Nifty's -0.4% move, supported by recent strong earnings.
With a market cap of ₹1,466.32 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
HINDWARE HME INOVATON flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 656.8% and Profit up 562.1%
- ●FII AccumulationFII holding increased by 1.79% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 10.9% outpacing sales growth of -9.1%
Latest HINDWARE HME INOVATON News
What changed recently?
Recent events, corporate actions, and announcements.
HINDWARE HME INOVATON valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for HINDWARE HME INOVATON, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
HINDWARE HME INOVATON technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for HINDWARE HME INOVATON — derived from the latest tape, not yesterday's close.
HINDWARE HME INOVATON last traded at ₹174.77 with an intraday range of ₹174–₹178.69 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹174.77| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 187.02 | +12.25 | +7.01% |
| R3 | 182.33 | +7.56 | +4.33% |
| R2 | 180.51 | +5.74 | +3.28% |
| R1 | 177.64 | +2.87 | +1.64% |
| PIVOT | 175.82 | 1.05 | 0.60% |
| CURRENT | 174.77 | — | — |
| S1 | 172.95 | -1.82 | -1.04% |
| S2 | 171.13 | -3.64 | -2.08% |
| S3 | 168.26 | -6.51 | -3.72% |
| S4 | 163.57 | -11.20 | -6.41% |
HINDWAREAP is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹175–₹178.01
Trading Inside opening range
HINDWARE HME INOVATON financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for HINDWARE HME INOVATON — consolidated or standalone — with margins, YoY growth and key ratios inline.
HINDWARE HME INOVATON reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,466.32 Cr. and reported EPS of ₹-0.72.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,523 | 2,510 ▼ 0.5% |
| Sales Growth YoY %Derived | -9.89% | -0.50% |
| Other Income | 41 | 35 ▼ 13.8% |
| Total Income | 2,564 | 2,545 ▼ 0.7% |
| 1,410 | 1,372 ▼ 2.7% | |
| Gross ProfitDerived | 1,113 | 1,138 ▲ 2.3% |
| Gross Margin %Derived | 44.11% | 45.34% |
| 970 | 941 ▼ 3.0% | |
| EBITDA (Operating Profit)Derived | 143 | 198 ▲ 38.1% |
| OPM %Derived | 5.67% | 7.87% |
| 182 | 135 ▼ 25.7% | |
| Profit Before Tax (PBT) | -58 | -8 ▲ 86.2% |
| -7 | -4 ▲ 38.6% | |
| Effective Tax %Derived | 11.85% | 52.83% |
| Profit/Loss from Discontinued Ops | 1 | 0 ▼ 92.1% |
| Total Profit for Period | -68 | -39 ▲ 42.3% |
| Less: Non-controlling Interests | — | 0 |
| Net Profit (Owner's PAT)Derived | -68 | -40 ▲ 41.7% |
| Net Profit Margin %Derived | -2.70% | -1.58% |
| PAT Growth YoY %Derived | -363.91% | 41.66% |
| Earnings Per Share (EPS ₹) | 8.16 | -4.74 ▼ 158.1% |
| Diluted Shares Outstanding (Cr) | 8 | 8 ▲ 0.0% |
| Share of Profit from Associates/JVs | -18 | -36 ▼ 98.8% |
| Other Comprehensive Income (Net of Tax) | 1 | -1 ▼ 139.7% |
| Total Expenses (incl. D&A & Interest) | 2,621 | 2,553 ▼ 2.6% |
| Material Cost % of RevenueDerived | 27.92% | 28.50% |
| Employee Cost % of RevenueDerived | 16.90% | 16.18% |
| Other Cost % of RevenueDerived | 21.54% | 21.29% |
| Interest Coverage (x)Derived | 0.23x | 1.14x |
| Period | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,613 | 1,775 ▲ 10.0% | 2,294 ▲ 29.2% | 2,873 ▲ 25.3% | 2,800 ▼ 2.5% | 2,523 ▼ 9.9% | 2,510 ▼ 0.5% | |
| Sales Growth YoY %Derived | — | 10.05% | 29.20% | 25.27% | -2.55% | -9.89% | -0.50% | |
| Other Income | 24 | 18 ▼ 25.7% | 29 ▲ 62.1% | 35 ▲ 18.2% | 37 ▲ 7.3% | 41 ▲ 9.1% | 35 ▼ 13.8% | |
| Total Income | 1,637 | 1,793 ▲ 9.5% | 2,323 ▲ 29.5% | 2,908 ▲ 25.2% | 2,837 ▼ 2.4% | 2,564 ▼ 9.6% | 2,545 ▼ 0.7% | |
1,074 | 1,194 ▲ 11.1% | 1,565 ▲ 31.1% | 1,637 ▲ 4.7% | 1,530 ▼ 6.6% | 1,410 ▼ 7.8% | 1,372 ▼ 2.7% | ||
| Gross ProfitDerived | 539 | 581 ▲ 7.9% | 729 ▲ 25.4% | 1,236 ▲ 69.5% | 1,270 ▲ 2.8% | 1,113 ▼ 12.4% | 1,138 ▲ 2.3% | |
| Gross Margin %Derived | 33.41% | 32.75% | 31.79% | 43.01% | 45.36% | 44.11% | 45.34% | |
451 | 438 ▼ 2.8% | 554 ▲ 26.5% | 989 ▲ 78.5% | 1,032 ▲ 4.4% | 970 ▼ 6.1% | 941 ▼ 3.0% | ||
| EBITDA (Operating Profit)Derived | 88 | 143 ▲ 62.3% | 175 ▲ 22.2% | 246 ▲ 41.0% | 238 ▼ 3.5% | 143 ▼ 39.8% | 198 ▲ 38.1% | |
| OPM %Derived | 5.47% | 8.06% | 7.62% | 8.58% | 8.49% | 5.67% | 7.87% | |
79 | 69 ▼ 13.3% | 161 ▲ 133.6% | 178 ▲ 10.9% | 218 ▲ 22.5% | 182 ▼ 16.5% | 135 ▼ 25.7% | ||
| Profit Before Tax (PBT) | 33 | 92 ▲ 178.6% | 245 ▲ 165.3% | 103 ▼ 58.0% | 57 ▼ 44.9% | -58 ▼ 201.7% | -8 ▲ 86.2% | |
10 | 38 ▲ 273.6% | 42 ▲ 11.1% | 37 ▼ 12.5% | 20 ▼ 45.3% | -7 ▼ 134.2% | -4 ▲ 38.6% | ||
| Effective Tax %Derived | 30.33% | 40.66% | 17.02% | 35.46% | 35.23% | 11.85% | 52.83% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | 1 | 0 ▼ 92.1% | |
| Total Profit for Period | 23 | 55 ▲ 137.3% | 202 ▲ 267.8% | 58 ▼ 71.5% | 28 ▼ 52.0% | -68 ▼ 346.1% | -39 ▲ 42.3% | |
| Less: Non-controlling Interests | — | — | — | 0 | 2 ▲ 304.3% | — ▼ 100.0% | 0 | |
| Net Profit (Owner's PAT)Derived | 23 | 55 ▲ 137.3% | 202 ▲ 267.8% | 57 ▼ 71.7% | 26 ▼ 54.9% | -68 ▼ 363.9% | -40 ▲ 41.7% | |
| Net Profit Margin %Derived | 1.43% | 3.09% | 8.79% | 1.99% | 0.92% | -2.70% | -1.58% | |
| PAT Growth YoY %Derived | — | 137.30% | 267.76% | -71.69% | -54.87% | -363.91% | 41.66% | |
| Earnings Per Share (EPS ₹) | 2.76 | 6.56 ▲ 137.7% | 24.11 ▲ 267.5% | 6.83 ▼ 71.7% | 3.08 ▼ 54.9% | 8.16 ▲ 164.9% | -4.74 ▼ 158.1% | |
| Diluted Shares Outstanding (Cr) | 8 | 8 ▲ 0.0% | 8 ▲ 0.0% | 8 ▲ 0.0% | 8 ▲ 0.0% | 8 ▲ 0.0% | 8 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | — | -2 | -9 ▼ 392.3% | -9 ▼ 2.4% | -18 ▼ 96.2% | -36 ▼ 98.8% | |
| Other Comprehensive Income (Net of Tax) | -0 | 2 ▲ 615.8% | 1 ▼ 73.0% | -1 ▼ 284.9% | -0 ▲ 91.8% | 1 ▲ 1675.0% | -1 ▼ 139.7% | |
| Total Expenses (incl. D&A & Interest) | 1,604 | 1,701 ▲ 6.0% | 2,078 ▲ 22.2% | 2,805 ▲ 35.0% | 2,780 ▼ 0.9% | 2,621 ▼ 5.7% | 2,553 ▼ 2.6% | |
| Material Cost % of RevenueDerived | — | — | — | 26.27% | 22.42% | 27.92% | 28.50% | |
| Employee Cost % of RevenueDerived | 10.99% | 10.19% | 10.07% | 14.00% | 15.37% | 16.90% | 16.18% | |
| Other Cost % of RevenueDerived | 16.95% | 14.50% | 14.09% | 20.43% | 21.50% | 21.54% | 21.29% | |
| Interest Coverage (x)Derived | 1.27x | 3.52x | 6.64x | 1.89x | 1.21x | 0.23x | 1.14x |
HINDWARE HME INOVATON segment analysis : revenue and profit mix.
Disclosed business segments at HINDWARE HME INOVATON with their share of revenue and profit, switchable between consolidated and standalone reporting.
HINDWARE HME INOVATON discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for HINDWARE HME INOVATON.
Our AI distills the core fundamental drivers supporting HINDWARE HME INOVATON, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
HINDWARE HME INOVATON's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.45. Balance sheet risk re-prices growth multiples fast.
HINDWARE HME INOVATON peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — HINDWARE HME INOVATON is highlighted for quick read-across.
Quick Compare
Peer Comparison
HINDWARE HME INOVATON chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for HINDWARE HME INOVATON — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
HINDWARE HME INOVATON delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for HINDWARE HME INOVATON over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in HINDWARE HME INOVATON stood at 61.0% of traded volume, against a 20-day average of 60.8%.
HINDWARE HME INOVATON announcements: results, concalls, ratings, M&A.
Filings HINDWARE HME INOVATON sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
HINDWARE HME INOVATON files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 93 documents below.
Updates
Hindware Home Innovation Limited has informed the Exchange regarding 'ESG Ratings update'.
Shareholders meeting
Hindware Home Innovation Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 18, 2026. Further,…
Shareholders meeting
Hindware Home Innovation Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 18, 2026
Copy of Newspaper Publication
Hindware Home Innovation Limited has informed the Exchange about Copy of Newspaper Publication
Investor Presentation
Hindware Home Innovation Limited has informed the Exchange about Investor Presentation
Investor decks & rating reports.
HINDWARE HME INOVATON dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue HINDWARE HME INOVATON has declared, sequenced by announce and record date.
HINDWARE HME INOVATON corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
HINDWARE HME INOVATON insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in HINDWARE HME INOVATON as reported to SEBI — buying and selling signals from the people who know the business best.
HINDWARE HME INOVATON insider activity below tracks 2 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Mr. Sandip Somany | Insider | 13 Mar 2025 | buy | +41.0 K | ₹78.06 L | ₹190.40 |
| Mr. Sandip Somany | Insider | 18 Feb 2025 | buy | +1.25 L | ₹2.29 Cr. | ₹183.46 |
About HINDWARE HME INOVATON: business, sector, key facts.
What HINDWARE HME INOVATON does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
HINDWARE HME INOVATON operates in the Sanitary Ware industry under the Consumer Durables sector, listed as NSE: HINDWAREAP, BSE: 542905.
Hindware Home Innovation Limited (formerly Somany Home Innovation Limited) is a prominent Indian company engaged in the manufacturing, sale, and trading of a diverse range of building products, consumer appliances, and related retail services. Their business operations encompass a significant portion of the home improvement and construction sectors within India.
A major segment of their business focuses on kitchen appliances. This includes a comprehensive selection of products such as chimneys, cooking ranges, dishwashers, sinks, water purifiers, microwaves, ovens, hobs, and various types of water heaters (instant, gas, heat pump, etc.). They also offer a wide array of cooling solutions including desert coolers, personal coolers, and window air conditioners, alongside a substantial line of fans (ceiling, exhaust, portable, table, pedestal, and wall-mounted).
Beyond kitchen appliances, Hindware Home Innovation provides an extensive catalog of kitchen and furniture fittings. This includes a broad range of hinges (soft close, corner, wide angle, etc.), drawer systems, lift-ups, and other related hardware components designed to enhance both functionality and aesthetics in kitchen and furniture design. The company's commitment to comprehensive home solutions is further demonstrated by their offerings in the broader building products sector.
The company's building products division encompasses a wide spectrum of sanitary ware, including water closets, wash basins, and urinals. They also offer a diverse selection of faucets (bathroom, kitchen, sensor), shower systems, and thermostats. Their wellness product line includes bathtubs, shower panels, shower enclosures, vanity units, whirlpools, and steam generators. Furthermore, they manufacture and distribute a wide range of tiles (glazed vitrified, ceramic, porcelain, etc.), plastic pipes and fittings (CPVC, UPVC, PVC, etc.), overhead water storage tanks, and related bath fittings.
In summary, Hindware Home Innovation Limited operates as a significant player in the Indian market, offering a comprehensive portfolio of products designed to meet the diverse needs of consumers and businesses involved in home construction, renovation, and improvement. Their integrated approach covering kitchen appliances, furniture fittings, and a wide array of building products positions them as a one-stop-shop for many home improvement projects.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- CERA SANITARYWARE (CERA) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about HINDWARE HME INOVATON (HINDWAREAP).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of HINDWARE HME INOVATON (HINDWAREAP)?
The current share price of HINDWARE HME INOVATON (HINDWAREAP) is ₹174.77. Today, the stock has declined by ₹1.80 (1.02%), trading in a range of ₹174.00 to ₹178.69. The stock opened at ₹175.00 with a trading volume of 41,766 shares.
02Is HINDWARE HME INOVATON stock a good investment for long-term?
HINDWARE HME INOVATON can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,466.32 Cr., P/E ratio of 0, ROE of -5.27%, and ROCE of 4.39%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of HINDWARE HME INOVATON stock?
The 52-week high price of HINDWARE HME INOVATON (HINDWAREAP) is ₹392.70, while the 52-week low is ₹170.30. Currently trading at ₹174.77, the stock is 2.62% above its 52-week low and 55.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy HINDWARE HME INOVATON stock at the current price?
Whether to buy HINDWARE HME INOVATON stock at ₹174.77 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 1.96. Today's performance shows a loss of 1.02%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of HINDWARE HME INOVATON and when is the next dividend?
HINDWARE HME INOVATON offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹174.77, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of HINDWARE HME INOVATON?
HINDWARE HME INOVATON's key financial metrics include: P/E Ratio: 0, P/B Ratio: 1.96, ROE: -5.27%, ROCE: 4.39%, Dividend Yield: 0%, EPS: ₹-0.72, Book Value: ₹88.10, and Debt-to-Equity: 0.95. The company's market cap stands at ₹1,466.32 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is HINDWARE HME INOVATON stock performing today in the market?
HINDWARE HME INOVATON stock opened at ₹175.00 and is currently trading at ₹174.77, showing a decline of ₹1.80 (1.02%). The intraday high is ₹178.69 and low is ₹174.00. The trading volume stands at 41,766 shares, indicating moderate market participation today.
08What is the P/E ratio of HINDWARE HME INOVATON and what does it indicate?
HINDWARE HME INOVATON has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹-0.72, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about HINDWARE HME INOVATON (HINDWAREAP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.